SEVERE MYOCARDITIS AS A COMPLICATION OF A NOVEL DUAL IMMUNOTHERAPY TREATMENT IN A PATIENT WITH ESOPHAGEAL CANCER

Giselle Alexandra Suero-Abreu,Miguel Gonzalez Velez,Luke Chong, Arturo Perez, Shalini R Krishnasamy, Tracy Proverbs-Singh,Martin Gutierrez

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY(2018)

引用 1|浏览1
暂无评分
摘要
Immunotherapy has been introduced into the treatment of numerous cancers with impressive survival benefits. However, several immune-related adverse events (irAEs) have been reported, including a spectrum of myocardial toxicities in 1-3% of patients, for which there is a need for increased awareness
更多
查看译文
关键词
esophageal cancer,immunotherapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要